WASHINGTON, DC – The US Food and Drug Administration has approved two clinical trials to assess the efficacy of cannabidiol (CBD), a nonpsychoactive plant cannabinoid, in the treatment of intractable pediatric epilepsy. The two approved trials will take place at New York Medical School and at the University of California at San Francisco, according to an online report in the […]
Read FDA Approves Clinical Trials Assessing CBD for Pediatric Epilepsy in its entirety on The Daily Chronic.
Want to stay up to date on marijuana reform & cannabis news worldwide? Visit The Daily Chronic - The Voice of the Reform Generation, the most comprehensive coverage of the cannabis community!
SOURCE: FDA Approves Clinical Trials Assessing CBD for Pediatric Epilepsy by NORML
. . . . . READ MOREWASHINGTON, DC — The US Supreme Court Monday declined to hear an appeal from medical marijuana advocacy groups who had challenged the DEA’s decision to maintain marijuana’s status as a Schedule I drug under the Controlled Substances Act, the category reserved for the most dangerous substances. The court denied in summary order a petition for a writ […]
Read US Supreme Court Rejects Marijuana Reclassification Appeal in its entirety on The Daily Chronic.
Want to stay up to date on marijuana reform & cannabis news worldwide? Visit The Daily Chronic - The Voice of the Reform Generation, the most comprehensive coverage of the cannabis community!
SOURCE: US Supreme Court Rejects Marijuana Reclassification Appeal by Phillip Smith
. . . . . READ MORE